FibroGen (NASDAQ:FGEN) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a report published on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, William Blair reiterated a market perform rating on shares of FibroGen in a research note on Monday, June 3rd. Check Out Our Latest Stock Report […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Initiates Coverage on Culp (NYSE:CULP)
Next post Mid-America Apartment Communities (NYSE:MAA) Lifted to “Overweight” at Wells Fargo & Company